New Zealand Insights

Image related to an article about Briscoe

As Briscoe hits a yearly high, is it too late to buy shares?

Consumer Cyclicals

With shares in Briscoe (NZE:BGP) currently trading close to a 52 week high, a question many on the sidelines probably have is: "was I too late to buy them"? The share price is up by around 10.7% over the past week. On a one-month basis...

NZE:BGP

Image related to an article about Skellerup Holdings

What's in store for shares in Skellerup Holdings?

Industrials

Shares in Skellerup Holdings (NZE:SKL) are currently trading at 3.37 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is well placed...

NZE:SKL

Image related to an article about Tilt Renewables

Will Tilt Renewables's price keep rising?

Utilities

Studies by leading experts into the power of price momentum show that stocks with the strongest price trends can potentially keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology...

NZE:TLT

Image related to an article about Genesis Energy

Genesis Energy (NZE:GNE): buy, sell or hold?

Utilities

Shares in Genesis Energy (NZE:GNE) are currently trading close to a 52 week high, with the share price up by around 3.59% - to 3.55 - over the past week. On a one-month basis, the Genesis Energy share price has risen by 10.9%. For inve...

NZE:GNE

Image related to an article about Arvida

Arvida passes these three dividend tests

Healthcare

With tens of billions paid out in dividends across the stock market each year, it's no surprise that investors pay close attention to the payouts from shares like Arvida (NZE:ARV).  The return 'boost' from cash payouts is a crucial par...

NZE:ARV

Image related to an article about EBOS

Why Ebos is a mid-cap stock for contrarian investors

Healthcare

Contrarian value investors are always on the look-out for shares that the market has overlooked. In times of economic uncertainty - when stock prices become erratic - good quality stocks can become cheaper. The question is whether Ebos...

NZE:EBO

Image related to an article about Delegat

Factors that could move the Delegat share price

Consumer Defensives

Covid-19 has shaken world markets and a question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect mid-cap shares like Delegat (NZE:DGL).  Shares in Del...

NZE:DGL

Image related to an article about Delegat

Which way to trade Delegat (NZE:DGL)?

Consumer Defensives

As any reader of this is probably aware, shares in Delegat (NZE:DGL) are currently trading close to a 52 week high, with the share price up by around 3.40% to 15.75 over the past week. On a one-month basis, the Delegat price has risen...

NZE:DGL

Image related to an article about Arvida

Why Arvida scores well in the hunt for dividend income

Healthcare

2020 has been a year of turmoil for stock market investors. Fortunately, the dividends on offer from shares like Arvida (NZE:ARV) can be a potentially better bet in the hunt for sustainable income whatever the economic weather.     Wit...

NZE:ARV

Image related to an article about Ikegps

Ikegps share price hits a one-year high

Industrials

Shares in Ikegps (NZE:IKE) are currently trading close to a 52 week high, with the share price up by around 2.59% to 1.2 over the past week. On a one-month basis, the Ikegps price has risen by 5.31%. For investors holding the stock (or...

NZE:IKE

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"